Feasibility Study of Preimplantation Genetic Diagnosis for Single-gene Disorders

NCT ID: NCT02502214

Last Updated: 2017-05-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-11-12

Study Completion Date

2017-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Preimplantation Genetic Diagnosis (PGD) for monogenic diseases is usually performed by multiplex PCR combining polymorphic microsatellites familial analysis and, where possible, couple-specific mutation detection. Single-cell multiplex PCR developments are costly and time-consuming. We propose to test and clinically validate a targeted next-generation sequencing approach for the PGD for cystic fibrosis. This technique would allow a PGD for probably almost every couple asking for it in our centre, without a previous couple-specific development (but only a preliminary familial analysis). It will be based on haplotyping using a large number of SNPs and mutation detection. A clinical validation will be performed by reanalysing non-transferable embryos obtained after PGD for cystic fibrosis, with couple's informed consent. Concordance of the results between PGD and reanalysis by NGS will be achieved and if validated, this technique may be applied to future PGD for cystic fibrosis in our centre. The same technique may then be applied for other PGD indications for which a set-up is often needed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preimplantation Diagnosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age\> or = 18 years
* Couples at risk of transmitting cystic fibrosis
* asking for a PGD in Strasbourg
* DNA samples available at the laboratory for:

* The couple
* A related with CFTR status known
* Having signed an informed consent

Exclusion Criteria

* Inability to give informed consent (understanding difficulties...)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Strasbourg, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Laboratoire de Diagnostic préimplantatoire Site du CMCO

Strasbourg, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Céline Moutou, MD

Role: CONTACT

03.69.55.34.21

Emmanuelle KIEFFER, PhD

Role: CONTACT

03.69.55.34.21

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Céline MOUTOU, MD

Role: primary

33 3 69 55 34 21

Emmanuelle KIEFFER, PhD

Role: backup

33 3 69 55 34 21

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

6195

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluating Prenatal Exome Sequencing Study
NCT05290701 ACTIVE_NOT_RECRUITING
Study of Gene Associations and Infertility
NCT01223092 ENROLLING_BY_INVITATION
Initiative for Clinical Long-read Sequencing
NCT06060184 NOT_YET_RECRUITING NA
Personalized Genomic Research
NCT01294345 COMPLETED
Finding Genes for Rare Diseases
NCT02724995 WITHDRAWN